DocuSign, Inc.DOCUNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank23
3Y CAGR-64.3%
5Y CAGR-46.9%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
-64.3%/yr
vs +44.2%/yr prior
5Y CAGR
-46.9%/yr
Recent deceleration
Acceleration
-108.5pp
Decelerating
Percentile
P23
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q1 20260.39%
Q4 2025-1.18%
Q3 20256.39%
Q2 20252.56%
Q1 20252.89%
Q4 20242.39%
Q3 20249.87%
Q2 2024-11.35%
Q1 202410.89%
Q4 20230.50%
Q3 202317.85%
Q2 2023-8.36%
Q1 20238.59%
Q4 2022-8.38%
Q3 202212.75%
Q2 20221.39%
Q1 20227.88%
Q4 20218.40%
Q3 202110.81%
Q2 20216.59%
Q1 20219.23%
Q4 202015.00%
Q3 202017.62%
Q2 20204.11%
Q1 20206.84%
Q4 20192.61%
Q3 201927.79%
Q2 2019-13.37%
Q1 201911.76%
Q4 201813.71%
Q3 2018-52.35%
Q2 2018202.46%
Q1 20184.04%
Q4 2017-5.24%
Q3 20174.66%
Q2 20170.00%